Host: Ileana L. Piña, MD, MPH, FAHA, FACC

Guest: Javed Butler, MD, MBA, MPH

Guest: Gregg C. Fonarow, MD

Guest: Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

Recent guideline updates and publications are leading to changes in care in patients with heart failure with reduced ejection fraction (HFrEF). What clinical evidence is driving recent changes to guideline directed medical therapy (GDMT) in HFrEF, and what real-world data exists that may impact the landscape of care and patient outcomes?